SCHEMBL95288

SCHEMBL95288

CCCCCCc1ccccc1-c1noc(CO)n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.50
PPARA Q07869 1/20 0.46
SPHK1 Q9NYA1 1/20 0.44
LIPG Q9Y5X9 1/20 0.44
HDAC1 Q13547 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
SPHK2 Q9NRA0 2/20 0.40
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL97645 0.90 PPARA (0.50) PPARASPHK1LIPGHDAC1HDAC2
SCHEMBL95287 0.88 PPARA (0.47) PPARASPHK1LIPGHDAC1HDAC2
SCHEMBL97644 0.84 PPARA (0.50) PPARASPHK1HDAC1HDAC2HDAC8
SCHEMBL1313635 0.77 SPHK1 (0.71) NOTUMSPHK1NPSR1SPHK2
SCHEMBL96221 0.76 NOTUM (0.48) NOTUMPPARALIPGATMNPSR1
SCHEMBL8157124 0.74 LIPG (0.62) PPARALIPGNR1H2NR1H3
SCHEMBL1921650 0.74 LIPG (0.62) PPARALIPGNR1H2NR1H3
SCHEMBL196217 0.74 LIPG (0.62) PPARALIPGNR1H2NR1H3
SCHEMBL1414266 0.74 LIPG (0.62) PPARALIPGNR1H2NR1H3
SCHEMBL9619382 0.74 LIPG (0.62) PPARALIPGNR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20090326008-A1 NF-kappa B Inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-12-31 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
EP-1797082-A1 CARBOSTYRIL COMPOUND Otsuka Pharmaceutical Company, Limited (JP) 2007-06-20 EP disclosed
WO-2006035954-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-04-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090326008-A1 NF-kappa B Inhibitor NFKBIA, NFKB2, IKBKB NOTUM 2694/4885PPARA 3385/4885SPHK1 1150/4885
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 NOTUM 2892/4885PPARA 1465/4885SPHK1 531/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 NOTUM 2892/4885PPARA 1465/4885SPHK1 531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.